Jim Healy is a Managing Partner at Sofinnova with a 20-year career there, investing in 32 companies. He holds board seats at ArriVent, BioAge, Rapport, and Seaport, and previously served on boards including Karuna and CinCor.








At firms with a similar stage, sector and check size.





One email when Jim's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckJim Healy is a Managing Partner at Sofinnova with a 20-year career there, investing in 32 companies. He holds board seats at ArriVent, BioAge, Rapport, and Seaport, and previously served on boards including Karuna and CinCor.
Jim Healy invests through Sofinnova Investments, which writes checks of $10M to $30M at series a, series b.
Email [email protected], the firm's inbox for founders, and name Jim in the subject. A warm intro from a founder Sofinnova Investments backed works better.
Bayer (Miles); Sanderling; Bayer (Miles); Sanderling.
Last updated 2026-10-15. Is this you? Ask for a correction.